Literature DB >> 17638803

Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer.

Henry Ptok1, Frank Marusch, Frank Meyer, Daniel Schubert, Ferdinand Koeckerling, Ingo Gastinger, Hans Lippert.   

Abstract

HYPOTHESIS: Despite the noninclusion of locally draining lymph nodes, limited resection of low-risk pT1 rectal cancer can achieve an adequate oncological outcome with lower morbidity and mortality compared with radical resection.
DESIGN: Based on the data of a prospective multicenter observational study performed from January 1, 2000, through December 31, 2001, patients with low-risk pT1 rectal cancer underwent analysis with regard to the early postoperative outcome and the oncological long-term results achieved after limited vs radical resection with curative intent.
SETTING: Two hundred eighty-two hospitals of all categories. PATIENTS: Four hundred seventy-nine patients with low-risk pT1 rectal cancer treated for cure.
INTERVENTIONS: Eighty-five patients (17.7%) underwent limited excision using a conventional transanal approach and 35 (7.3%) using transanal endoscopic microsurgery. The remaining 359 (74.9%) underwent radical resection. MAIN OUTCOME MEASURES: Postoperative morbidity and mortality, local recurrence rate, and tumor-free and overall survival.
RESULTS: In comparison with radical resection, limited resection was associated with fewer general (25.1% vs 7.5%; P<.001) and specific (22.8% vs 9.2%; P<.001) postoperative complications. After a mean follow-up of 44 months, patients who underwent limited resection had a significantly higher 5-year local tumor recurrence rate than did those who underwent radical resection (6.0% vs 2.0%; P = .049), but tumor-free survival did not differ.
CONCLUSION: Limited resection of pT1 low-risk rectal cancer can result in an oncologically acceptable outcome but must nevertheless be considered an oncological compromise compared with radical resection.

Entities:  

Mesh:

Year:  2007        PMID: 17638803     DOI: 10.1001/archsurg.142.7.649

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  23 in total

1.  Transanal endoscopic video-assisted (TEVA) excision.

Authors:  Madhu Ragupathi; Dominique Vande Maele; Javier Nieto; T Bartley Pickron; Eric M Haas
Journal:  Surg Endosc       Date:  2012-06-23       Impact factor: 4.584

Review 2.  Transanal Endoscopic Microsurgery.

Authors:  Theodore John Saclarides
Journal:  Clin Colon Rectal Surg       Date:  2015-09

Review 3.  [Surgery for rectal cancer].

Authors:  C J Krones; M Stumpf; V Schumpelick
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

Review 4.  Treatment of stage II-III rectal cancer patients.

Authors:  Miranda B Kim; Theodore S Hong; Jennifer Y Wo
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

Review 5.  Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.

Authors:  Marco E Allaix; Alberto Arezzo; Mario Morino
Journal:  Surg Endosc       Date:  2016-02-22       Impact factor: 4.584

6.  The Role of Transanal Surgery in the Management of T1 Rectal Cancers.

Authors:  Imran Hassan; Paul E Wise; David A Margolin; James W Fleshman
Journal:  J Gastrointest Surg       Date:  2015-06-06       Impact factor: 3.452

Review 7.  Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond.

Authors:  Azah A Althumairi; Susan L Gearhart
Journal:  J Gastrointest Oncol       Date:  2015-06

8.  Transanal single-port microsurgery for rectal tumors: minimal invasive surgery under spinal anesthesia.

Authors:  Taek-Gu Lee; Sang-Jeon Lee
Journal:  Surg Endosc       Date:  2013-09-06       Impact factor: 4.584

9.  Primary local excision of stage 1 rectal cancer is not associated with worse oncological outcomes when compared with major resection.

Authors:  Ryan Cohen; Cameron Platell
Journal:  Int J Colorectal Dis       Date:  2020-01-23       Impact factor: 2.571

10.  A population-based comparison of overall and disease-specific survival following local excision or abdominoperineal resection for stage I rectal adenocarcinoma.

Authors:  Michelle Olsheski; David Schwartz; Justin Rineer; Angela Wortham; Sonal Sura; Gainosuke Sugiyama; Marvin Rotman; David Schreiber
Journal:  J Gastrointest Cancer       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.